C12N 2720/12234
Use of virus or viral component as vaccine
Official title: Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
C12N2720/12234 (Use of virus or viral component as vaccine) appears on 20 US grants and 20 published applications in this corpus.
Search patents in C12N- Granted patents
- 20
- Published applications
- 20
- Assignees
- 17
- Inventors
- 47
- Latest grant
- 24 Dec 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 2 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 1 |
| 2005 | 1 | 1 |
| 2006 | 0 | 0 |
| 2007 | 1 | 1 |
| 2008 | 0 | 0 |
| 2009 | 1 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 1 | 1 |
| 2013 | 0 | 2 |
| 2014 | 1 | 1 |
| 2015 | 0 | 0 |
| 2016 | 3 | 1 |
| 2017 | 0 | 1 |
| 2018 | 1 | 2 |
| 2019 | 1 | 2 |
| 2020 | 1 | 1 |
| 2021 | 2 | 1 |
| 2022 | 0 | 1 |
| 2023 | 1 | 0 |
| 2024 | 1 | 0 |
| 2025 | 0 | 2 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Vaccine against infectious bronchitis24 Dec 2024US 12,171,825 B2Zoetis Services LLC
- Vaccines against avian reoviruses14 Nov 2023US 11,813,321 B2Biomune Company
- Vaccine against infectious bronchitis31 Aug 2021US 11,103,573 B2Zoetis Services LLC
- Avian reovirus vaccines17 Aug 2021US 11,090,377 B2University of Georgia Research Foundation, Inc.
- Avian reovirus vaccines17 Mar 2020US 10,588,958 B2University of Georgia Research Foundations, Inc.
- Muns fusion protein capable of forming microspheres and uses thereof27 Aug 2026US 2026/0248905 A1Universidade De Santiago De Compostela
- Vaccine against infectious bronchitis25 Sep 2025US 2025/0295752 A1Zoetis Services LLC
- Compositions and methods for expressing antigens on cell membrane20 Feb 2025US 2025/0057937 A1Zoetis Services LLC
- Vaccine against infectious bronchitis9 Jun 2022US 2022/0175911 A1Zoetis Services LLC
- New vaccines against avian reoviruses7 Oct 2021US 2021/0308253 A1Biomune Company
Most cited
By later US patents
- Viral purification methods41US 7,223,585 B2Oncolytics Biotech Inc. · 2007
- Viral purification methods34US 8,685,734 B2Oncolytics Biotech Inc. · 2014
- Inactivated vaccines14US 5,914,113 AAkzo Nobel N. V. · 1999
- Antigenic class of avian reoviruses11US 6,951,650 B1Akzo Nobel N. V. · 2005
- Immortal avian cell line to grow avian and animal viruses to produce vaccines9US 5,989,805 ABoard of Trustees operating Michigan State University · 1999